STOCK TITAN

Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Singular Genomics Systems, Inc. (Nasdaq: OMIC) will announce its first quarter 2024 financial results on May 14, 2024, after the market closes. The company focuses on next-generation sequencing and spatial multiomics technologies. The management will host a conference call to discuss the results. Investors can join the call or access the webcast on investor.singulargenomics.com.

Singular Genomics Systems, Inc. (Nasdaq: OMIC) annuncerà i risultati finanziari del primo trimestre del 2024 il 14 maggio 2024, dopo la chiusura del mercato. La società è specializzata in tecnologie di sequenziamento di nuova generazione e multiomiche spaziali. La direzione terrà una conferenza telefonica per discutere i risultati. Gli investitori possono partecipare alla chiamata o accedere al webcast su investor.singulargenomics.com.
Singular Genomics Systems, Inc. (Nasdaq: OMIC) anunciará sus resultados financieros del primer trimestre de 2024 el 14 de mayo de 2024, después del cierre del mercado. La compañía se enfoca en tecnologías de secuenciación de próxima generación y multiómicas espaciales. La gerencia organizará una llamada de conferencia para discutir los resultados. Los inversores pueden unirse a la llamada o acceder a la transmisión web en investor.singulargenomics.com.
싱귤러 지노믹스 시스템즈, 인크. (나스닥: OMIC)는 2024년 5월 14일, 시장 폐쇄 후 2024년도 1분기 재무 결과를 발표할 예정입니다. 이 회사는 차세대 시퀀싱 및 공간 멀티오믹스 기술에 중점을 둡니다. 경영진은 결과를 논의하기 위해 컨퍼런스 콜을 주관할 예정입니다. 투자자는 이 콜에 참여하거나 investor.singulargenomics.com에서 웹캐스트에 접속할 수 있습니다.
Singular Genomics Systems, Inc. (Nasdaq : OMIC) annoncera ses résultats financiers pour le premier trimestre 2024 le 14 mai 2024, après la fermeture du marché. L'entreprise se concentre sur les technologies de séquençage de nouvelle génération et de multiomiques spatiales. La direction organisera une conférence téléphonique pour discuter des résultats. Les investisseurs peuvent rejoindre l'appel ou accéder à la webdiffusion sur investor.singulargenomics.com.
Singular Genomics Systems, Inc. (Nasdaq: OMIC) wird seine Finanzergebnisse für das erste Quartal 2024 am 14. Mai 2024 nach Börsenschluss bekannt geben. Das Unternehmen konzentriert sich auf Technologien der nächsten Generation Sequenzierung und räumlichen Multiomics. Das Management wird eine Telefonkonferenz veranstalten, um die Ergebnisse zu besprechen. Investoren können sich der Anrufkonferenz anschließen oder den Webcast auf investor.singulargenomics.com aufrufen.
Positive
  • None.
Negative
  • None.

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 14, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing 1-888-506-0062 for domestic callers or 1-973-528-0011 for international callers and using conference ID 173302 approximately five minutes prior to the start time. A live and archived webcast of the event will be available at investor.singulargenomics.com in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4® Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, the company is currently developing the G4X™ Spatial Sequencer, which will leverage Singular’s proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact
Philip Taylor
ir@singulargenomics.com

Media Contact
Matt Browning
pr@singulargenomics.com

 


FAQ

When will Singular Genomics Systems report its first quarter 2024 financial results?

Singular Genomics Systems will report its first quarter 2024 financial results on May 14, 2024, after the market closes.

What technologies does Singular Genomics Systems focus on?

Singular Genomics Systems focuses on novel next-generation sequencing (NGS) and spatial multiomics technologies.

How can investors listen to the conference call discussing the financial results?

Investors can dial 1-888-506-0062 (domestic) or 1-973-528-0011 (international) using conference ID 173302 to listen to the conference call.

Where can investors access the live and archived webcast of the event?

Investors can access the live and archived webcast of the event at investor.singulargenomics.com in the Presentations & Events section.

Singular Genomics Systems, Inc.

NASDAQ:OMIC

OMIC Rankings

OMIC Latest News

OMIC Stock Data

58.11M
2.50M
13.9%
54.53%
3.52%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
SAN DIEGO